In gastric cancer and head and neck squamous cell carcinoma patients, MIF levels were elevated in the plasma from patients with accelerated cancer progression, and plasma-MIF concentration correlated negatively with response to immune-checkpoint inhibition [56], [57]. Here, MIF is linked to head and neck squamous cell carcinoma.